ArticleCureus2026
Gastric Mucormycosis in a Patient With Uncontrolled Diabetes: A Rare Presentation.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mucormycosis is a rapidly progressive, invasive fungal infection that predominantly affects immunocompromised individuals. Although rhino-orbital-cerebral disease is the most common clinical presentation, gastrointestinal mucormycosis is rare and associated with higher mortality rates. We report the case of a 55-year-old woman with uncontrolled diabetes mellitus and chronic airway disease who presented with septic shock secondary to emphysematous pyelonephritis and diabetic ketoacidosis. She was treated with insulin infusion and intravenous meropenem for 14 days. Despite recovery from acute kidney injury, she continued to experience persistent nausea and poor oral intake. Upper gastrointestinal endoscopy demonstrated gastric ulceration, and histopathological examination confirmed gastric mucormycosis. Liposomal amphotericin B was initiated with subsequent improvement in patient appetite and resolution of nausea. This case highlights the importance of early endoscopic evaluation and tissue diagnosis in high-risk patients with persistent gastrointestinal symptoms during recovery from critical illness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.